Literature DB >> 17805235

The impact of HIV on chronic kidney disease outcomes.

A I Choi1, R A Rodriguez, P Bacchetti, D Bertenthal, P A Volberding, A M O'Hare.   

Abstract

Chronic kidney disease (CKD) is a known complication of the human immunodeficiency virus (HIV) but outcomes among HIV-infected patients with kidney disease are unknown. We studied a national sample of 202,927 patients with CKD (stage 3 or higher) for death, end-stage renal disease (ESRD) and the mean annual rate of decline in estimated glomerular filtration rate (eGFR) over a median period of 3.8 years. Within this sample, 0.3% of the patients were diagnosed with HIV, 43.5% were diabetic, whereas the remainder had neither disease. In this national CKD cohort, HIV-infected black patients were at higher risk of death, a similar risk for ESRD and loss of eGFR than black patients with diabetes. HIV-infected white patients experienced higher rates of death but a lower risk of ESRD than their counterparts with diabetes. Our results highlight a need to study mortality and mechanisms of ESRD in the HIV infected population.

Entities:  

Mesh:

Year:  2007        PMID: 17805235     DOI: 10.1038/sj.ki.5002541

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  37 in total

1.  Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infection.

Authors:  Takashi Shinha; Deming Mi; Ziyue Liu; Christie M Orschell; Michael M Lederman; Samir K Gupta
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-26       Impact factor: 2.205

2.  Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.

Authors:  Vasantha Jotwani; Yongmei Li; Carl Grunfeld; Andy I Choi; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-12-28       Impact factor: 8.860

Review 3.  Renal issues in HIV infection.

Authors:  Robert C Kalayjian
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

4.  Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Authors:  Robert C Kalayjian; Bryan Lau; Rhoderick N Mechekano; Heidi M Crane; Benigno Rodriguez; Robert A Salata; Zipporah Krishnasami; James H Willig; Jeffrey N Martin; Richard D Moore; Joseph J Eron; Mari M Kitahata
Journal:  AIDS       Date:  2012-09-24       Impact factor: 4.177

5.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

6.  Kidney Disease in HIV-Infected Persons.

Authors:  Robert C Kalayjian
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 7.  Cardiovascular complications in HIV management: past, present, and future.

Authors:  Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

Review 8.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Racial differences in chronic kidney disease incidence and progression among individuals with HIV.

Authors:  Deidra C Crews; Bernard G Jaar
Journal:  Nat Clin Pract Nephrol       Date:  2008-09-23

10.  HIV viremia and changes in kidney function.

Authors:  Chris T Longenecker; Rebecca Scherzer; Peter Bacchetti; Cora E Lewis; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.